Biotech stock sends Wall Street surprising signal
Kardigan (KARD) didn’t just raise $400 million. The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is not a simple optimism. It’s prejudiced. Biotech businesses might toss around early research, big potential markets, and future ...
The Source
THE STREET
Business
Costco makes moves amid shaky economy
THE STREET·1h ago·3 min read
Business
Walmart is selling a 2-in-1 laptop and tablet for just $72 during its summer deals event
THE STREET·1h ago·3 min read
Business
Amazon is selling Skechers sneakers for 53% off during Prime Day sales
THE STREET·1h ago·3 min read
Business
SoftBank’s founder picks side in space data center fight
THE STREET·1h ago·3 min read
Related
On this beat
Business
Walmart is selling a 2-in-1 laptop and tablet for just $72 during its summer deals event
THE STREET·1h ago·3 min read
Business
Amazon is selling Skechers sneakers for 53% off during Prime Day sales
THE STREET·1h ago·3 min read
Business
Costco makes moves amid shaky economy
THE STREET·1h ago·3 min read
Business
Most Platforms Want More of Your Attention. Pinterest Wants You to Close the App—and That’s the Point
INC·1h ago·3 min read